A comprehensive search of the PubMed/Medline database was undertaken for all publications in English up to February, 2010. The following search terms were used in combination with “multiple sclerosis OR MS”: “vitamin D OR 25-hydroxyvitamin D”, “Epstein-Barr virus OR EBV”, “smoking”, “genet*”, “environment*”, “timing”, “exposure”, “clinically isolated syndrome OR CIS”, “radiologically isolated syndrome OR RIS”, “immunology”, and “migration”. Abstracts were manually searched for relevance,
ReviewMultiple sclerosis: risk factors, prodromes, and potential causal pathways
Introduction
Multiple sclerosis (MS) is the most common disease of the CNS to cause permanent disability in young adults.1 On the basis of strong circumstantial evidence, MS is thought to be an organ-specific autoimmune disorder,1, 2 but much remains to be understood about the initiation of the disease. MS seems unlikely to result from a single causative event; instead, the disease seems to develop in genetically susceptible populations as a result of environmental exposures.
The concept of a prodrome is being studied intensively in neurological disease, and is defined as the time period between the onset of decline in a baseline level of functioning until criteria for disease diagnosis are met.3 The constellation of symptoms in a prodrome tends to be non-specific, particularly in the early stages. Thus, prodromal symptoms are not prospectively deterministic, and research is directed towards identifying which patients with prodromal symptoms will later develop disease.3 The findings of these studies will help us to understand the trajectory of changes in the disease process from genetic risk factors to clinical diagnosis.3
The question of whether there is a prodrome in MS has so far not been extensively studied. A diagnosis of MS is made after a historical review of events in a patient's life, findings observed on neurological examination, data acquired from diagnostic tests, and after the exclusion of other diseases that could account for the clinical and paraclinical findings.4 Patients with MS typically present with a clinically isolated syndrome (CIS), which is defined by a distinct first neurological event with observed demyelination involving the optic nerve, cerebrum, cerebellum, brainstem, or spinal cord.5 CIS has, until recently, been thought to be the first sign of MS. However, radiological abnormalities might be identified in the absence of clinical symptoms, leading to use of the term “radiologically isolated syndrome” (RIS) to specifically describe individuals who have structural anomalies in the CNS that are highly suggestive of demyelination.6 Individuals with RIS are at increased risk of developing MS.6 This observation, in conjunction with evidence for known MS risk factors that act many years before disease onset, renders unsurprising the notion that the disease develops subclinically. Thus, the existence of a prodrome in MS is compelling, but has so far received little attention. Endophenotypes, measurable components unseen by the unaided eye along the pathway of disease development, are also likely to exist in MS.7 In this Review, we summarise current understanding of disease susceptibility to elucidate potential causal pathways and endophenotypes, and suggest avenues for further study.
Section snippets
Genetic risk factors
The development of MS must start in individuals who are genetically susceptible. The importance of genetic factors in susceptibility to MS has been shown by genetic epidemiological studies.8 Family studies assessing risks to relatives of MS probands have revealed a marked familial aggregation of the disease.9, 10, 11, 12 First-degree relatives are generally at 10–25 times greater risk of developing MS than the general population. This risk correlates with degree of kinship (figure 1), with
Environmental risk factors
Although genes are needed for MS to develop, genetic epidemiological studies clearly illustrate a prominent role for the environment in determining MS risk. Factors with the strongest evidence for involvement in MS are Epstein-Barr virus (EBV), smoking, and latitude/vitamin D. Reports on other factors such as geographical region and data from migration studies suggest that the timing of exposure is a crucial determinant of risk for MS, particularly for some factors that operate very early in
Symptoms and signs before MS diagnosis
A substantial number of people who are diagnosed with MS recall earlier symptoms that could be attributable to a first demyelinating event. Individuals who later develop MS might also experience fatigue, depression, and/or cognitive impairment before the diagnosis of MS.82, 83 Many patients first present with CIS, but recent work has highlighted that radiological (RIS) and immunological changes might occur earlier.
Potential causal pathways
Our current understanding of MS development is that RIS leads to CIS and then eventually to MS. The associated risk factors for MS also seem to delineate a putative causal cascade (figure 3).130 Factors largely defined from birth (ie, sex, HLA status, place of birth) require the incitement of environmental factors (vitamin D deficiency, late EBV exposure) to develop the abnormalities required that subsequently lead to MS. The latitude effect (early life) and infectious-mononucleosis
Endophenotypes
An endophenotype is an intermediate phenotype that fills the gap in the causal chain between genes and clinical disease,136 and is typically defined by several traits and/or characteristics that in isolation might not be considered pathological. Endophenotypes are most commonly applied to psychiatric diseases, but can be applied to any complex disorder.7 The disease markers that are used to define the endophenotype are usually associated with disease in the population, might be heritable,
Conclusions and future perspectives
Modelling all known risk factors for MS (table 3) might enhance our ability to predict who will develop the disease and to select individuals in whom to intensively study the MS prodrome. This could help us to elucidate the steps leading to the development of MS and to identify robust and easily measurable biomarkers and endophenotypes.
Some attempts at combining risk factors have been made, leading to substantial improvements in the potential prediction of MS (table 4). The most comprehensive
Search strategy and selection criteria
References (150)
- et al.
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis
Lancet Neurol
(2005) - et al.
Genetics of multiple sclerosis
Lancet Neurol
(2004) - et al.
Parent-of-origin effect in multiple sclerosis: observations in half-siblings
Lancet
(2004) - et al.
Histocompatibility determinants in multiple sclerosis, with special reference to clinical course
Lancet
(1973) - et al.
HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course
Am J Hum Genet
(2003) - et al.
Sex ratio of multiple sclerosis in Canada: a longitudinal study
Lancet Neurol
(2006) - et al.
Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study
Lancet Neurol
(2007) Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study
Am J Clin Nutr
(2007)- et al.
Vitamin D and multiple sclerosis
Lancet Neurol
(2010) - et al.
Migrant studies in multiple sclerosis
Prog Neurobiol
(1995)
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
Lancet Neurol
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
Am J Pathol
Multiple sclerosis
N Engl J Med
Multiple sclerosis: the environment and causation
Curr Opin Neurol
The schizophrenia prodrome
Am J Psychiatry
Multiple sclerosis
Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome
Neurology
The endophenotype concept in psychiatric genetics
Psychol Med
Age-adjusted recurrence risks for relatives of patients with multiple sclerosis
Brain
Multiple sclerosis: updated risks for relatives
Am J Med Genet
Twin concordance and sibling recurrence rates in multiple sclerosis
Proc Natl Acad Sci USA
Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia
Hum Mol Genet
Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance
Hum Mol Genet
HLA-DR15 is associated with lower age at onset in multiple sclerosis
Ann Neurol
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis
Hum Mol Genet
The inheritance of resistance alleles in multiple sclerosis
PLoS Genet
HLA-DRB1 and multiple sclerosis in Malta
Neurology
Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility
Proc Natl Acad Sci USA
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
Nat Genet
Risk alleles for multiple sclerosis identified by a genomewide study
N Engl J Med
Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution
Neurology
Parent-of-origin effects in MS. Observations from avuncular pairs
Neurology
Maternal transmission of multiple sclerosis in a Dutch population
Arch Neurol
Parent-of-origin effect in multiple sclerosis. Observations from interracial matings
Neurology
Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex
Hum Mol Genet
Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography
Ann Neurol
Increasing prevalence and incidence of multiple sclerosis in South East Wales
J Neurol Neurosurg Psychiatry
Temporal trends in the incidence of multiple sclerosis: a systematic review
Neurology
Sex differences in autoimmune disease
Nat Immunol
Environmental risk factors for multiple sclerosis. Part I: the role of infection
Ann Neurol
Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis
Ann Neurol
An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study
Neurology
Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis
JAMA
Multiple sclerosis after infectious mononucleosis
Arch Neurol
Association of infectious mononucleosis with multiple sclerosis. A population-based study
Neuroepidemiology
Pediatric multiple sclerosis
Nat Rev Neurol
High seroprevalence of Epstein-Barr virus in children with multiple sclerosis
Neurology
Smoking is a risk factor for multiple sclerosis: a metanalysis [sic]
Mult Scler
Cigarette smoking and incidence of multiple sclerosis
Am J Epidemiol
Cited by (416)
Impact of tobacco smoking on disease-specific outcomes in common neurological disorders: A scoping review
2024, Journal of Clinical NeuroscienceThe Role of MRI in Differentiating Demyelinating and Inflammatory (not Infectious) Myelopathies
2023, Seminars in Ultrasound, CT and MRIAssociation between human herpesviruses and multiple sclerosis: A systematic review and meta-analysis
2023, Microbial PathogenesisCurrent therapies for neurological disorders and their limitations
2023, Phytonutrients and Neurological Disorders: Therapeutic and Toxicological AspectsActivation of complement: A potent biomarker in multiple sclerosis
2023, Translational Neuroimmunology: Multiple Sclerosis: Volume 8Monoclonal antibodies in multiple sclerosis treatment
2023, Translational Neuroimmunology: Multiple Sclerosis: Volume 8